Founder of Cancer Recovery Foundation Responds to World Cancer Report 2014

Breast Cancer News, Uncategorized No Comments

Greg Anderson, Founder & CEO of Cancer Recovery Foundation International, Responds to World Cancer Report 2014

The new World Cancer Report issued by the World Health Organization (WHO), recently predicted worldwide cancer rates to rise by 57 percent in the next two decades.  The report used its strongest language ever to highlight the problem including the dire prediction of “an imminent human disaster” if we do not act.WorldCancerReport

The report issued a sobering warning:  “We cannot treat our way out of the cancer problem. More commitment to prevention and early detection is desperately needed in order to complement improved treatments and address the alarming rise in cancer burden globally.”

The global burden of cancer is the single most important reason why the Cancer Recovery Foundation Group of charities, including Breast Cancer Charities of America and Children’s Cancer Recovery Foundation maintain a major commitment to medical missions through their International Aid programs.

The organizations’ medical missions program distributes cancer treatment medicines, cancer diagnostic and treatment equipment as well as ancillary medical supplies to mission hospitals globally.  Recent recipients include cancer treatment centers in Guatemala, Honduras, Grenada, Kenya, Ghana, Liberia, DR Congo, Zambia, Zimbabwe, The Philippines and Viet Nam.

“We believe we are our brothers (and sisters) keepers,” said Greg Anderson.  “When we began our work, we clearly stated our mission was to help ALL people prevent and survive cancer.  Our International Aid program fulfills that mission mandate.”

The World Cancer Report said the growing cancer burden disproportionately impacts developing nations—the very countries that have the least resources to respond to the problem.  Approximately 60 percent of the world’s cancer cases and approximately 70 percent of the world’s cancer death occur in Africa, Asia, Central and South America.

“This is exactly why we are committed to helping in this way,” said Anderson.  More information on how The Breast Cancer Charities of America helps, visit their website.



Proton Therapy: New Less Toxic Treatment for Early Stage Breast Cancer

Breast Cancer News, iGoPink Blog No Comments

Proton Therapy is a relatively newer form of cancer treatment. It has shown remarkable promise and advantages over conventional therapy in the treatment of breast cancer.

Proton radiation therapy is non-invasive treatment that offers a low-risk option for early breast cancer patients. It has less impact on the healthy tissue near the tumor site that is being treated with the proton therapy. This is because the proton goes directly in to the tumor with pinpoint precision and stays within the tumor. This is unlike traditional therapies that have an exit point. Compared to traditional radiation, proton therapy does not leave any burn marks and does not cause any cosmetic or tissue damage.

ProtonTherapy

Image Credit: University of Florida Proton Therapy Institute

Researchers and physicians stress that proton therapy is not a replacement for a lumpectomy but rather a less toxic path of treatment afterwards. At a proton therapy center, the average breast cancer patient will receive a 30 minute to 1 hour per day for a total of 10 days of proton treatment on an outpatient basis. Compared to radiation and/or chemotherapy which require at least 5 to 7 weeks of treatment, proton therapy allows the patient a faster approach to treatment.
Other strong points for Proton Therapy leading the way as a new treatment are:

  • Treatment offers faster recovery time with minimal side effects
  • Pain-less for most patients
  • Little to no hair loss
  • Proton radiation has little to no impact on patient energy levels

Currently in the United States there are 12 Proton Therapy Centers with several more in the planning stages at leading treatment hospitals and facilities.
Current operating centers include:



PRESS Forward Against Breast Cancer

Breast Cancer News, iGoPink Blog No Comments

Breast Cancer Charities of America (BCCA) exists for one reason—to eliminate breast cancer as a life-threatening disease.  Our central focus is on educating, empowering and encouraging all women to become pro-active in preventing breast cancer and, if diagnosed, in surviving breast cancer.

We offer leading edge, state-of-the-art, research-backed programs that focus on all that women can do in addition to medical care.  Our services include nutrition, exercise, and social support all the while defusing the fear that often accompanies breast cancer.  And we provide help now with emergency financial assistance to medicines and medical supplies to women in poverty.

Join Breast Cancer Charities as we P-R-E-S-S Forward in the fight against breast cancer….

Prevention

Studies show that 8 of 10 breast cancers can be prevented.   Prevention—not just early detection.  Breast cancer prevention is the new frontier.  Excellent studies show that prevention is possible.  We lead the way with our Vitamin D Promise program.

Research

Though the “New Era Cancer Research Fund” we underwrite less-toxic, minimally-invasive diagnosis and treatment options.  This includes research on topics such as the link between Vitamin D and a reduction in cancer; how food choices impact your body during treatment and studies on Proton Therapy as a first-line treatment.

Education

Education is power in preventing and surviving breast cancer.  From teaching breast self exams to wise exercise, from managing post-treatment side-effects to mobilizing the mind for healing, we guide and support women to actively participate in health and healing.  Our University Education Program teaches students the lifestyle choices they can make at an early age to prevent breast cancer.

Survival

BCCA’s integrated cancer care program supports and complements conventional medical treatment.  The program encompasses the whole person—body, mind and spirit.  While accomplished in addition to conventional medical care, we understand it takes more than medicine to get well and stay well.

Support

When breast cancer strikes, it impacts the entire family and all areas of their life, especially financially.  We have designed our Help Now Fund to assist with the basic needs of cancer patients in need.  The demand is huge and we limit our funding to past-due rents and utilities.  Our commitment: no woman will go through breast cancer without a roof over her head and the basics of daily needs.

iStock_000017006241Medium
 

We PRESS Forward in the fight against breast cancer.  We inspire hope.  We nurture healing.  We renew life.

The Breast Cancer Charities of America.  We are the new voice of breast cancer.  We are passionate, filled with energy and a vision.  And we will not stop until breast cancer is no longer a life-threatening disease.

Join us.  Make your voice heard.  It’s a new day in the world of breast cancer.



Komen Controversy: Opportunity to Examine “Life-saving Mammograms”

Breast Cancer News, iGoPink Blog No Comments

The daily news reports over the resignations of the Founder and the President of Komen for the Cure are filled with drama.  That Nancy Brinker’s life’s work seems to have been tarnished makes for compelling media.  But the best outcome of this coverage could be that America engages in a serious discussion about the dangers of breast cancer screening.

Mammography: Time for a New Screening Protocol
Despite the loud protests of many breast cancer organizations and advocacy groups, the U.S. Preventative Services Task Force got it right.  Women do not need as many mammograms as they are receiving.

In November of 2009, the Task Force updated its recommendations on breast cancer screening.  Previous standards stated that women be screened annually from the age of 40 onwards.  A furor arose over the Task Force recommendation that women between 40-49 years old should not have annual mammograms.

Overtreatment of breast cancer is epidemic, a toxic tragedy that leaves the health of hundreds-of-thousands of women compromised for the remainder of their lives.   The over-treatment starts with over-diagnosis in early screening for breast cancer—the belief that early detection is the best protection.  It is not.

Cancer screening enjoys virtually unquestioned cultural acceptance.  On the surface, the logic of screening for breast cancer seems unassailable.  A mammogram can pick up lesions as small as 0.5 cm, a size that you are seldom able to feel.  The test can detect up to 85-percent of all breast cancers.  In short, screening for breast cancer seems to make sense.

But the screening is not without significant shortcomings and health risks.  With mammography, the weak points of screening include:

  • If a woman has dense breasts, a lump is typically not visible.
  • In women under 50-years of age, at least 25-percent of the tumors will be missed.
  • In women with smaller breasts, the screening is even less accurate.

According to Dr. Susan Love, mammograms will miss cancers between 9- and 20-percent of the time.  And if nothing is found, women are given a false sense of security that all is well.

There’s more.  Approximately 5-percent of all mammograms read as positive for cancer.  Of these five, 97.5-percent will be false positives.  This means no cancer is present.  In other words, out of every 1,000 mammograms, fifty are read as positive and between one and two will actually turn out to be breast cancer.  The fact is mammograms are, for the most part, inconclusive.  Yet we treat them as the gold standard of breast cancer screening.

Early screening brings a host of related risks of which American women remain uninformed.  Radiation from routine mammography poses significant cumulative risks of initiating and promoting breast cancer.  Contrary to conventional assurances that radiation exposure from mammography is minimal and tolerable, we have known for at least forty years that the pre-menopausal breast is highly sensitive to radiation.  Each exposure increases breast cancer risk resulting in at least a cumulative 10-percent increased risk over ten years of pre-menopausal screening.

Mammography also poses a risk from breast compression.  As early as 1928, physicians were warned to handle “cancerous breasts with care for fear of accidentally disseminating cells” and spreading cancer.  Mammography requires tight and often painful compression of the breast, particularly in pre-menopausal women. Experts have warned that compression may lead to distant and lethal spread of malignant cells by rupturing small blood vessels in or around small, as yet undetected breast cancers.

Mammography’s reliability is seldom discussed by the medical providers with their patients.  These discussions must become the norm.  The message:

  1.  Missed cancers resulting in false negative readings are especially common in pre-menopausal women.  This is due to the dense and highly glandular structure of their breasts and increased proliferation late in their menstrual cycle.
  2. Missed cancers are also common in post-menopausal women on estrogen replacement therapy, as about 20 percent develop breast densities that make their mammograms as difficult to read as those of pre-menopausal women.
  3. False positive readings, which are mistakenly diagnosed cancers, are common with mammography.  Again, they are common in women on estrogen replacement therapy.  False positives result in needless anxiety, more mammograms and unnecessary biopsies.  For a woman with multiple high-risk factors, including a strong family history of breast cancer, prolonged use of contraceptives and early menarche, the cumulative risk of false positives increases to “as high as 100 percent” over a decade’s screening.

The widespread and virtually unchallenged acceptance of this early screening protocol has resulted in a dramatic increase in the diagnosis of ductal carcinoma-in-situ (DCIS), a pre-invasive cancer.  DCIS was historically recognized as micro-calcifications.  For decades, they were considered benign but suspicious.  The screening guidance was another test in six months to determine if there were noticeable changes.

Today DCIS is widely treated as actual breast cancer.  The treatment is defended by the medical community because with current testing and diagnostic procedures, it is not possible to know if a given DCIS may become malignant or if it will disappear.  Some 80-percent of all DCIS never become invasive even if left untreated. Furthermore, the breast cancer mortality from DCIS is the same, approximately 1-percent, both for women diagnosed and treated early and for those diagnosed later following the development of invasive cancer.  Early detection of DCIS does not reduce mortality.  This fact is startling and seems counterintuitive.  But the data speaks the truth.

A Clarion Call:  New Screening Guidelines
Studies do show that screening mammography does reduce the death rate in women over 50 years of age by approximately 30-percent.  Early detection in this age group works.  However, equal results are available from much less-invasive and non-toxic clinical breast examinations coupled with breast self-exams.

What is more worrisome are new studies which show that in women under 50, screening mammography can increase the death rate from breast cancer by up to 50-percent.  The suspected reason is because these women accumulate radiation toxicity.  Even more, other studies show screening mammography leads to more frequent diagnosis and aggressive treatment of breast cancer.  These same studies also show aggressive screening and treatment does not decrease overall breast cancer mortality.

America clearly needs new breast cancer screening guidelines.  Below is a wise approach widely accepted in countries other than the United States for women under 50-years old:

  • Employ annual clinical breast examinations and monthly breast self-examinations as your primary early detection protocol.
  • Once a year, every year, without fail, schedule an appointment with your healthcare provider to perform a clinical breast examination.
  • Once a month, every month, without fail, set aside 15 minutes to conduct thorough breast self-examination.  Perform it on the first day of menstruation.
  • Schedule a mammogram only if needed for diagnosis of a suspected lump.  Even then, be sure to schedule that mammogram within the first 14 days of your menstrual cycle.

For women over 50-years old:

  • Employ annual clinical breast examinations and monthly breast self-examinations as your primary early detection protocol.
  • Once a year, every year, without fail, schedule an appointment with your healthcare provider to perform a clinical breast examination.
  • Once a month, every month, without fail, set aside 15 minutes to conduct thorough breast self-examination.  Schedule it on the first day of your period if you are still menstruating.
  • Schedule a mammogram if you discover a suspicious change in the feel of your breast.  Even then, be sure to schedule that mammogram within the first 14 days of your menstrual cycle if you are still menstruating.
  • Employ mammography screening every other year.

Annual clinical breast examination combined with monthly breast self-examination is a safe and effective alternative to mammography.  That most breast cancers are first recognized by women themselves was admitted in 1985 by the American Cancer Society, the leading advocate of routine mammography for all women over the age of 40.  “We must keep in mind the fact that at least 90-percent of the women who develop breast carcinoma discover the tumors themselves”  Furthermore, as previously shown, “training increases reported breast self-examination frequency, confidence, and the number of small tumors found.”

A pooled analysis of several studies showed that women who regularly performed breast self-examinations detected their cancers much earlier and with fewer positives nodes and smaller tumors than women failing to examine themselves.  Plus breast self examinations also enhance earlier detection of missed cancers, especially in pre-menopausal women.

Let’s be clear.  The effectiveness of breast self-exam critically depends on careful training by skilled professionals.  Further, confidence in self-exams is enhanced with annual clinical breast examinations by an experienced professional using structured individual training.  And finally, this strategy requires discipline.  Every year, a clinical breast exam; every month, a breast self-exam.  If a woman cannot or will not meet that standard of discipline, the entire process stands in jeopardy.

The question of more screening extends to what have come to be known as the “breast cancer genes,” BRCA1 (BReast CAncer gene one) and BRCA2 (BReast CAncer gene two). Women who inherit a mutation in either of these genes have a higher-than-average risk of developing breast cancer and ovarian cancer.

The function of the BRCA genes is to keep breast cells growing normally and prevent any cancer cell growth.  When these genes contain the mutations that are passed from generation to generation, they do not function normally and breast cancer risk increases. Abnormal BRCA1 and BRCA2 genes may account for between 5 and 10-percent of all breast cancers.

Should you choose to undergo genetic testing to find out your status? A genetic test involves giving a blood sample that can be analyzed to pick up any abnormalities in these genes.  Testing for these abnormalities is not done routinely, but it may be considered on the basis of your family history and personal situation.  But remember that most people who develop breast cancer have no family history of the disease.

Do mammograms save lives?  The answer is very, very few.  But the massive over-diagnosis and overtreatment they initiate makes routine mammography a very real health hazard.  Were mammograms an automobile, The National Highway Traffic Safety Administration would have recalled them years ago.  A less-is-more breast cancer screening protocol must replace our current policy.  This is the first necessary shift in the evolving integrated breast cancer care model.  Current annual mammography guidelines are exposing nearly all American women to exceedingly high levels of radiation.  It’s part of the toxic tragedy that is making us sicker—and poorer.



Men can get breast cancer too!

Breast Cancer News, iGoPink Blog No Comments

When you think of breast cancer, automatically images of women (some you may know personally) enter your mind. However, this disease does not discriminate amongst race or even sex. Although women have a 1 to8 chance of getting breast cancer at some time in their life, men are less likely to seek treatment and therefore, it can be fatal.  Often times men are embarrassed to be screened for breast cancer. Also, in men there is less breast tissue and it is more likely to spread. For this reason, it is important for men to report any lump that they discover.

Dr. Vaughan practices with SSM St. Charles Clinic Medical Group. “People are sometimes surprised to learn that men have breast tissue,” Dr. Vaughan continues. “Women develop more breast tissue and milk ducts during puberty, however men also have breast ducts, and ductal carcinoma – malignancy of the ducts – is the most common form of male breast cancer.”

The BRCA-1 or BRCA-2 gene mutation is thought to be responsible for breast cancer in men, as well as, women & prostate cancer in men. Other risk factors include age, heavy alcohol consumption, estrogen exposure, family history, liver disease, radiation treatments to the chest and obesity.

Men who are diagnosed will usually undergo a Masectomy to remove the cancerous tissue. Surgery, chemotherapy or hormone therapy may follow.



Elizabeth Edwards chose to spend her final days with family

Breast Cancer News, iGoPink Blog No Comments

    Elizabeth Edwards died at her home on Tuesday, December 7, after a long battle with Breast Cancer.  Doctors stopped all treatment for Edwards because the cancer had spread to her liver and bones. Instead of remaining at the hospital, she decided to go home to spend her last days with her family. When faced with the inevitable decision to be strong in her last days, Edwards decided to embrace death because it is a natural part of life. In her Monday Facebook statement, she said, “The days of our lives, for all of us, are numbered.”

   Making a patient with cancer that has spread all over comfortable is really difficult. When breast cancer spreads in the body, bone is the most common place it goes. It’s hard to think of bone as living tissue, but breaking an arm or a leg hurts because our bones are very much alive. Uncontrollable, malignant growth in bone can be excruciatingly painful, especially if the cancerous growths impinge on nerves.

    While most dying patients are confined to a hospital in ICU with IV tubes hooked up to them, Edwards made the choice to spend her final days with the people she cared for the most. And in this case, it was the right choice.



To Test or Not to Test?

Breast Cancer News, iGoPink Blog No Comments

I was browsing through the October issue of Better Homes and Garden when I came across this article about Breast Cancer. The article starts off with a story about a woman named Kathy Smith who’s best friend Valerie age 44, was diagnosed with breast cancer in 2006.  Immediately Kathy tried to schedule a mammogram for herself. Luckily she did because it revealed a cluster of suspicious cells that could be classified as stage IIB. When Kathy was finally in remission, she saw a news report that shocked her.  According to studies, the U.S. Preventative Services Task Force suggests that most women in their 40s should not bother getting routine mammograms because screenings do more harm than good. And that women over 50 could skip their mammogram every other year. Kathy wondered why they would make these conclusions considering that her and Valerie would not be alive if they did not go for their routine checkups. The trouble with this way of thinking is that no one can know if they fall into that category of women who will be afflicted with breast cancer before age 50. Since breast cancer can strike anyone at any age, it is better to be safe. How can you be sure if you are in the minority that has breast cancer. Not testing for it is just irresponsible. Celebrities such as Sheryl Crow & Olivia Newton John who were diagnosed in their 40s both defended the decision to have routine mammograms. With rumors that health insurance companies might stop coverage over routine mammograms, congress passed a Health Care Reform Bill to mandate the task force’s guidelines be ignored.

The task force says that the guidelines were not meant to discourage women from getting mammograms, just to raise awareness of the drawbacks of mammograms (such as a false positive).  The important thing is for women to have open communication with their gynecologist. Sometimes a mammogram will find something that isn’t cancer or is non aggressive cancer. The risk is that if you don’t have an annual mammogram you could potentially miss a fast acting cancer that can potentially kill you. Some patients will simply forgo treatments if their gyno doesn’t recommend them.

According to a recent study 67% of doctors will stop offering routine mammograms to women in their 40s. While only 29% of patients said they would stop the frequency of  screenings.  You have to wonder why someone else has a say in an issue concerning your health.  The most concerning factor is that some women are forgoing screenings because these guidelines from the task force went public. Mammography is best among the best diagnostic tools for breast cancer  but it is far from perfect. Out of 2,000 women who get tested, half will get a false positive. This will lead to follow-up tests such as biopsies. For every 1,904 women who get tested, one woman’s life will be saved. By age 50, one woman out of 1,339 women will be saved. The task force looked at these numbers and figured that it was not necessary that every woman be tested. The problem is that if this scares women away from routine mammograms, the minority that could be diagnosed, will not seek testing.  Health experts suggest talking to your doctor before making any rash decisions about mammograms. They will ask you about your lifestyle, family history, and possibilities of false positives. The decision to get a mammogram should be an individual one and not decided by a task force. Kathy Smith is grateful that she got screened in her 40s and so are countless other women.



Pregnant With Breast Cancer: 5 Questions Women Need to Ask

Breast Cancer News, iGoPink Blog No Comments


By Deborah Kotz

Posted: February 9, 2009

As earth-shattering as a diagnosis of breast cancer can be, it’s even worse for women who are pregnant at the time. A new study from the University of Texas M.D. Anderson Cancer Center, though, provides some reassuring news for those with what’s commonly called pregnancy-associated breast cancer: It doesn’t appear to be any more deadly—contrary to what was once thought—than breast cancer that occurs in women who aren’t pregnant.

There are, however, many complicating factors that women still need to consider if they detect a breast lump while pregnant. (And young breast cancer patients who are not expecting a baby are advised to avoid pregnancy at least until after treatment.) Here are five important questions that women need to ask their doctors:

1. Mammogram or MRI? Small studies have shown that mammography poses little risk to the developing fetus if a lead shield is placed over a woman’s belly to block any radiation scatter, according to breastcancer.org. Unfortunately, the X-ray isn’t great at detecting tumors; researchers have shown that the test misses anywhere from 22 percent to 38 percent of malignancies in pregnant women compared with 15 percent of cancers in nonpregnant women. Ultrasound may be used before a mammogram to distinguish clear fluid-filled cysts (which are harmless) from solid lumps, but they can’t differentiate the harmful solid lumps from the benign ones. Magnetic resonance imaging is more sensitive at finding breast tumors than mammography, but it’s generally not performed during pregnancy because doctors worry about unknown health risks to the fetus posed by the test’s strong magnetic fields.

2. How will  s urgery and chemotherapy be timed? When possible, doctors prefer to delay treatment until a woman is past her first trimester, when all the fetal organs have developed. Unfortunately, risks to the baby from surgical anesthesia and chemotherapy can’t be completely eliminated, and doctors usually discuss these risks in the context of helping women decide whether to continue with the pregnancy. Chemotherapy timing is particularly complicated because while it shouldn’t be given during the first trimester, it also shouldn’t be given within three to four weeks prior to delivery, according to the American Cancer Society. That’s because it lowers a woman’s blood count, raising her risk for bleeding and infections during childbirth.

3. Lumpectomy or mastectomy? Radiation treatments, which are routinely given after a lumpectomy, aren’t safe for the baby at any stage in the womb, so women with early-stage tumors might want to opt for a mastectomy instead. Those who require radiation to prevent a local recurrence will have to delay these treatments until after childbirth.

4. When should’t amoxifen start? Tamoxifen, which blocks estrogen, isn’t given until after pregnancy because of studies indicating that it may be associated with certain birth defects.

5. Breast feeding, safe or not? If you’re currently being treated for breast cancer, breastfeeding isn’t considered safe. That goes for both chemotherapy and a hormone-blocking therapy like tamoxifen. For women who’ve finished all their treatment and who haven’t had a double mastectomy, breastfeeding is still possible and often considered safe for both mom and baby.

Article courtesy of  http://health.usnews.com



Alcohol companies’ pink campaigns anger breast cancer survivors

Breast Cancer News, iGoPink Blog No Comments

By Liz Szabo, USA TODAY

Consumers who want to support breast cancer research through shopping can choose from pink T-shirts, lip gloss and, increasingly, booze.Mike’s Hard Lemonade now comes in a pink variety. Pink wines sport pink ribbons. And Chambord, which markets pink vodka and liqueurs, urges people to “pink their drink,” saying that “by adding a splash of Chambord to any cocktail, you’re supporting breast cancer awareness year-round.”

FACEBOOK CHAT: Dr. Susan Love answers your breast cancer questionsALCOHOL: Women weigh heart benefits vs. breast cancer risk

All of them have given money to breast cancer causes — and highlight the donations in their ads.

That has led to criticism by some breast cancer survivors, who say it’s hypocritical to raise money for research while selling a product that contributes to the disease.

Both the American Cancer Society and the National Cancer Institute say even moderate drinking increases breast cancer risk.

“Anybody trying to sell alcohol to promote breast cancer awareness should be ashamed of themselves,” says Barbara Brenner, executive director of Breast Cancer Action, an advocacy group.

Chambord’s website notes that its Pink Your Drink campaign has raised more than $50,000 in donations for the Breast Cancer Network of Strength and other patient groups.

Mike’s Hard Lemonade has given $500,000 over the past two years to the Breast Cancer Research Foundation, company President Phil O’Neil says. The company was inspired by the loss of an employee named Jacqueline who died after a long battle with breast cancer.

“The donations we make to breast cancer research are not tied to sales; they are our way of honoring Jacqueline,” O’Neil said in a statement.

In many cases, cause-related marketing is not about charity, says Dwight Burlingame, associate executive director of the Center on Philanthropy at Indiana University: “These businesses are promoting their product.”

At least one breast cancer charity is walking away from alcohol-related gifts. “We have a partnership with alcohol, and I don’t understand it, either,” says Cindy Geoghegan, the new interim CEO at Breast Cancer Network for Strength. “Those kinds of relationships will not continue.”

And though the Breast Cancer Research Foundation appreciates donations from Mike’s Hard Lemonade, spokeswoman Anna DeLuca says, the group “in no way, shape or form endorses the consumption of alcohol.”

“This donation does not constitute a partnership,” DeLuca says.

 Courtesy of www.usatoday.com



Elite Medical Skin and Laser Center

Breast Cancer News, iGoPink Blog, iGoPink News No Comments

Elite Medical Skin & Laser Center is representing The Breast Cancer Charities of America for the month of May. Along with excepting donations throughout the month, Elite is having a special on Botox. This Thursday 5/27, Botox will be $10 per unit. $.20 of every unit sold will be donated to The Breast Cancer Charities of America. Schedule your appointment today for these great specials and help us in our search for the cure!
635 Rayford RoadSpring, TX 77386
Contact: 281-214-7777

Thank you for all your support!